Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: Insights from the HORIZONS-AMI trial
- Mikkel M. Schoos
- , Giuseppe De Luca
- , George D. Dangas
- , Peter Clemmensen
- , Girma Minalu Ayele
- , Roxana Mehran
- , Gregg W. Stone
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations